About Synplogen
Synplogen is a company based in Tsuruoka (Japan) founded in 2017. Synplogen operates in a competitive market with competitors including Inflammatix, DnaNudge, Agendia, KromaTiD and InDevR, among others.
- Headquarter Tsuruoka, Japan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
i-nest capital
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Synplogen
Investors in Synplogen
Synplogen has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include i-nest capital and JAFCO Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital services are provided to support innovative startups.
|
Locked | Locked | Locked | |
|
Buyouts are targeted through venture capital and private equity investments.
|
Locked | Locked | Locked |
Investor details for Synplogen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synplogen
Investment portfolio details for Synplogen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Synplogen
Detailed financials for Synplogen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synplogen Comparisons
Peer comparison for Synplogen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synplogen
Synplogen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, DnaNudge, Agendia, KromaTiD and InDevR, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Lab-on-chip wearable systems for genetic diagnosis are provided.
|
|
| Locked | Locked | Locked |
Genomic diagnostic products for cancer treatment are provided.
|
|
| Locked | Locked | Locked |
Molecular and genetic tests for detecting disease-causing mutations are provided.
|
|
| Locked | Locked | Locked |
Biotherapeutics, vaccines, and diagnostic products are manufactured and developed.
|
|
| Locked | Locked | Locked |
Genomic tests for urologic cancers are developed and commercialized.
|
Detailed competitors of Synplogen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synplogen
Complete news archive for Synplogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synplogen
Synplogen was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Synplogen is headquartered in Tsuruoka, Japan. It is registered at Tsuruoka, Yamagata, Japan.
Junichi Sugahara is the current CEO of Synplogen.
Synplogen was founded in 2017 in Tsuruoka, Japan, as a biotechnology firm focused on DNA synthesis innovations. Core technology, including OGAB, enables simultaneous synthesis of up to 50 DNA strands via Bacillus subtilis, while Combi-OGCB supports gene cluster production from microbes. Services encompass long-chain DNA synthesis, DNA library creation, and microbial-based genetic engineering production, serving medical, biotechnological, and food sectors.
Synplogen's top competitors include Inflammatix, Agendia and KromaTiD.
Synplogen has 2 investors. Key investors include i-nest capital, and JAFCO Group.